Accelerating Innovation at Leica Biosystems
Free Cash Flow
($ in millions)
DANAHER CORPORATION
Total Cash Flows:
Total cash provided by operating activities (GAAP)
Total cash used in investing activities (GAAP)
Total cash (used in) provided by financing activities (GAAP)
Free Cash Flow:
Total cash provided by operating activities (GAAP)
Less: payments for additions to property, plant & equipment (capital expenditures)
(GAAP)
Full Year Ending
Six-Month Period Ended
Full Year Ended
December 31,
2021 5
Year-over-Year
December 31,
July 2, 2021 5
July 3, 2020 5
Change
2015 6
>$7,500 $
3,991 $
2,271
$
3,828
*
$
(2,060) $
(20,329)
$
(14,912)
*
$
(588) $
3,745
$
9,050
Plus: proceeds from sales of property, plant & equipment (capital disposals)
(GAAP)
Free cash flow (non-GAAP)
>$7,500 $
3,991 $
2,271
~ 75.5% $
3,828
(1,500)
(556)
(288)
(633)
15
13
64
>$6,000 $
3,448 $
1,984
~
74.0% $
3,259
5
Items above reflect results from continuing operations.
6
Items above reflect continuing operations as reported in 2016 which included Fortive and Envista.
We do not provide these GAAP measures because of the inherent difficulty in predicting and estimating the future impact and timing of investing and financing cash flows.
We define free cash flow as operating cash flows from continuing operations, less payments for additions to property, plant and equipment from continuing operations
("capital expenditures") plus the proceeds from sales of plant, property and equipment from continuing operations ("capital disposals").
9View entire presentation